Financials

News Ideas Discussions Technicals Forecast Seasonals

SYRE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Spyre Therapeutics, Inc.

Total assets of SYRE for Q2 24 is 436.07 M USD, 10.57% less than the previous Q1 24. And total liabilities decreased by 81.61% in Q2 24 to 61.68 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—